Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (21)

Search Parameters:
Authors = Hsiuying Wang ORCID = 0000-0002-5863-0756

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
20 pages, 2252 KiB  
Review
Medical Benefits and Polymer Applications of Grapes
by Hsiuying Wang
Polymers 2025, 17(6), 750; https://doi.org/10.3390/polym17060750 - 12 Mar 2025
Cited by 2 | Viewed by 2617
Abstract
Grapes are a fruit with origins dating back to ancient times. Their first recorded use, as mentioned in the Bible, was in winemaking. The abundance of bioactive compounds in grapes makes them highly valuable. So far, many varieties of cultivated grapes have been [...] Read more.
Grapes are a fruit with origins dating back to ancient times. Their first recorded use, as mentioned in the Bible, was in winemaking. The abundance of bioactive compounds in grapes makes them highly valuable. So far, many varieties of cultivated grapes have been developed for table grapes, wine grapes, and raisin production. In addition to these uses, since grapes contain a variety of nutrients, including resveratrol, flavonoids (such as flavonols, anthocyanins, and catechins), melatonin, vitamins, acids, tannins, and other antioxidants, grape extracts have been widely studied for medical applications. This paper reviews the medical effects of these compounds on cancer, cardiovascular disease, brain and neurological disorders, eye diseases, skin disorders, kidney health, diabetes, and gastric diseases, along with the medical applications of grapes in drug delivery, wound dressing, and tissue engineering. In addition, the limitations of the grapes-derived polymers and future research perspectives are discussed. These benefits highlight that the value of grapes extends far beyond their traditional use in wine and raisin production. Full article
(This article belongs to the Special Issue Biopolymer-Based Materials in Medical Applications)
Show Figures

Figure 1

15 pages, 3267 KiB  
Article
EWMA Control Chart Integrated with Time Series Models for COVID-19 Surveillance
by Chen-Rui Hsu and Hsiuying Wang
Mathematics 2025, 13(1), 115; https://doi.org/10.3390/math13010115 - 30 Dec 2024
Cited by 2 | Viewed by 1232
Abstract
The global outbreak of coronavirus disease 2019 (COVID-19) has posed a severe threat to public health and caused widespread socioeconomic disruptions in the past several years. While the pandemic has subsided, it is essential to explore effective disease surveillance tools to aid in [...] Read more.
The global outbreak of coronavirus disease 2019 (COVID-19) has posed a severe threat to public health and caused widespread socioeconomic disruptions in the past several years. While the pandemic has subsided, it is essential to explore effective disease surveillance tools to aid in controlling future pandemics. Several studies have proposed methods to capture the epidemic trend and forecast new daily confirmed cases. In this study, we propose the use of exponentially weighted moving average (EWMA) control charts integrated with time series models to monitor the number of daily new confirmed cases of COVID-19. The conventional EWMA control chart directly monitors the number of daily new confirmed cases. The proposed methods, however, monitor the residuals of time series models fitted to these data. In this study, two time series models—the auto-regressive integrated moving average (ARIMA) model and the vector auto-regressive moving average (VARMA) model—are considered. The results are compared with those of the conventional EWMA control chart using three datasets from India, Malaysia, and Thailand. The findings demonstrate that the proposed method can detect disease outbreak signals earlier than conventional control charts. Full article
(This article belongs to the Special Issue Statistical Analysis and Data Science for Complex Data)
Show Figures

Figure 1

18 pages, 662 KiB  
Review
A Review of Nanotechnology in microRNA Detection and Drug Delivery
by Hsiuying Wang
Cells 2024, 13(15), 1277; https://doi.org/10.3390/cells13151277 - 30 Jul 2024
Cited by 20 | Viewed by 5597
Abstract
MicroRNAs (miRNAs) are small, non-coding RNAs that play a crucial role in regulating gene expression. Dysfunction in miRNAs can lead to various diseases, including cancers, neurological disorders, and cardiovascular conditions. To date, approximately 2000 miRNAs have been identified in humans. These small molecules [...] Read more.
MicroRNAs (miRNAs) are small, non-coding RNAs that play a crucial role in regulating gene expression. Dysfunction in miRNAs can lead to various diseases, including cancers, neurological disorders, and cardiovascular conditions. To date, approximately 2000 miRNAs have been identified in humans. These small molecules have shown promise as disease biomarkers and potential therapeutic targets. Therefore, identifying miRNA biomarkers for diseases and developing effective miRNA drug delivery systems are essential. Nanotechnology offers promising new approaches to addressing scientific and medical challenges. Traditional miRNA detection methods include next-generation sequencing, microarrays, Northern blotting, and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Nanotechnology can serve as an effective alternative to Northern blotting and RT-qPCR for miRNA detection. Moreover, nanomaterials exhibit unique properties that differ from larger counterparts, enabling miRNA therapeutics to more effectively enter target cells, reduce degradation in the bloodstream, and be released in specific tissues or cells. This paper reviews the application of nanotechnology in miRNA detection and drug delivery systems. Given that miRNA therapeutics are still in the developing stages, nanotechnology holds great promise for accelerating miRNA therapeutics development. Full article
(This article belongs to the Special Issue microRNA as Biomarker II)
Show Figures

Graphical abstract

15 pages, 1528 KiB  
Review
The Potential of Collagen Treatment for Comorbid Diseases
by Hsiuying Wang
Polymers 2023, 15(19), 3999; https://doi.org/10.3390/polym15193999 - 5 Oct 2023
Cited by 8 | Viewed by 10534
Abstract
Collagen, the most abundant protein in our bodies, plays a crucial role in maintaining the structural integrity of various tissues and organs. Beyond its involvement in skin elasticity and joint health, emerging research suggests that collagen may significantly impact the treatment of complex [...] Read more.
Collagen, the most abundant protein in our bodies, plays a crucial role in maintaining the structural integrity of various tissues and organs. Beyond its involvement in skin elasticity and joint health, emerging research suggests that collagen may significantly impact the treatment of complex diseases, particularly those associated with tissue damage and inflammation. The versatile functions of collagen, including skin regeneration, improving joint health, and increasing bone strength, make it potentially useful in treating different diseases. To the best of my knowledge, the strategy of using collagen to treat comorbid diseases has not been widely studied. This paper aims to explore the potential of collagen in treating comorbid diseases, including rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, sarcopenia, gastroesophageal reflux, periodontitis, skin aging, and diabetes mellitus. Collagen-based therapies have shown promise in managing comorbidities due to their versatile properties. The multifaceted nature of collagen positions it as a promising candidate for treating complex diseases and addressing comorbid conditions. Its roles in wound healing, musculoskeletal disorders, cardiovascular health, and gastrointestinal conditions highlight the diverse therapeutic applications of collagen in the context of comorbidity management. Full article
(This article belongs to the Special Issue Advanced Biopolymer-Based Composites)
Show Figures

Figure 1

3 pages, 170 KiB  
Editorial
Biomaterials in Medical Applications
by Hsiuying Wang
Polymers 2023, 15(4), 847; https://doi.org/10.3390/polym15040847 - 8 Feb 2023
Cited by 17 | Viewed by 3000
Abstract
Natural biomaterials are materials extracted from living organisms or their by-products [...] Full article
(This article belongs to the Special Issue Biomaterials in Medical Applications)
11 pages, 2140 KiB  
Article
The Human Pre-miRNA Distance Distribution for Exploring Disease Association
by Hsiuying Wang and Ching Ho
Int. J. Mol. Sci. 2023, 24(2), 1009; https://doi.org/10.3390/ijms24021009 - 5 Jan 2023
Cited by 4 | Viewed by 2109
Abstract
MicroRNAs (miRNAs), playing an important role in cell differentiation, development, gene regulation, and apoptosis, have attracted much attention in recent years. miRNAs were shown to be involved in the mechanisms of various diseases, and certainly, they can be employed as useful disease biomarkers. [...] Read more.
MicroRNAs (miRNAs), playing an important role in cell differentiation, development, gene regulation, and apoptosis, have attracted much attention in recent years. miRNAs were shown to be involved in the mechanisms of various diseases, and certainly, they can be employed as useful disease biomarkers. The phylogenetic tree analysis of miRNA biomarkers is a useful tool to investigate the association between various diseases as well as the association between viruses and disease. In addition to the phylogenetic tree analysis, a more advanced study is to use the miRNA distance distribution to evaluate the similarity of the miRNA biomarkers. The mature miRNA distance distribution based on mature miRNA sequences has been derived. The averages of the pairwise distances of miRNA biomarkers for several associated diseases were shown to be smaller than the overall mean of all miRNAs, which indicates the high similarity of miRNA biomarkers for associated diseases. In addition to the mature miRNA, the precursor miRNA (pre-miRNA) may be more useful to explore the similarity of miRNAs because the mature miRNA duplex is released from the pre-miRNA. Therefore, in this study, the distance distributions based on human pre-miRNA stem–loop sequences were derived. The 1917 human miRNA stem-loop sequences in the miRBase dataset were used to derive the pre-miRNA distance distribution, and this is the first study to provide the distance distribution based on the human pre-miRNAs. The similarity of miRNA biomarkers for several associated diseases or vaccines was examined using the derived distribution, and the results show that the similarity of pre-miRNA biomarkers may be a feasible way to help explore the disease association. Full article
(This article belongs to the Collection Feature Papers in Molecular Genetics and Genomics)
Show Figures

Figure 1

13 pages, 3497 KiB  
Article
Phylogenetic Tree Selection by Testing Substitution Number in Clade
by Weishan Chen and Hsiuying Wang
Diversity 2022, 14(7), 543; https://doi.org/10.3390/d14070543 - 6 Jul 2022
Cited by 6 | Viewed by 3820
Abstract
The phylogenetic tree is a widely-used tool to show the evolutionary relationship between taxa. There are many types of phylogenetic trees proposed in the literature such as maximum likelihood, neighbor-joining, and UPGMA trees. The topologies of different types of trees are not the [...] Read more.
The phylogenetic tree is a widely-used tool to show the evolutionary relationship between taxa. There are many types of phylogenetic trees proposed in the literature such as maximum likelihood, neighbor-joining, and UPGMA trees. The topologies of different types of trees are not the same. Even for the same type of tree, the topologies are different when they embed different nucleotide substitution models, such as the JC69 model, K80 model, TN93 model, and so on. Although each type of tree has its advantages, selecting a suitable tree among these choices becomes a challenging problem. In this study, we propose a method based on testing the nucleotide substitution number between sequences to select trees. An Ebolavirus example is used to illustrate the method. In addition, this approach can select a suitable nucleotide substitution model for a particular type of tree. For this ebolavirus example, the JC69 model is the selected substitution model for the maximum likelihood tree. Full article
(This article belongs to the Special Issue Modeling the Ecology and Evolution of Biodiversity)
Show Figures

Figure 1

2 pages, 173 KiB  
Editorial
microRNA Biomarkers in Clinical Study
by Hsiuying Wang and Yi-Hau Chen
Biomolecules 2021, 11(12), 1810; https://doi.org/10.3390/biom11121810 - 2 Dec 2021
Cited by 3 | Viewed by 1812
Abstract
MicroRNAs (miRNAs), short non-coding RNAs, are involved in the initiation and progression of many human diseases that also play a key role in immune response and drug metabolism modulation [...] Full article
(This article belongs to the Special Issue microRNA Biomarkers in Clinical Study)
20 pages, 1754 KiB  
Review
A Review of the Effects of Collagen Treatment in Clinical Studies
by Hsiuying Wang
Polymers 2021, 13(22), 3868; https://doi.org/10.3390/polym13223868 - 9 Nov 2021
Cited by 147 | Viewed by 60420
Abstract
Collagen, an abundant extracellular matrix protein, has been found to have a lot of pharmaceuticals, medicine, food, and cosmetics applications. Increased knowledge of collagen sources, extraction techniques, structure, and properties in the last decades has helped develop more collagen-based products and tissue engineering [...] Read more.
Collagen, an abundant extracellular matrix protein, has been found to have a lot of pharmaceuticals, medicine, food, and cosmetics applications. Increased knowledge of collagen sources, extraction techniques, structure, and properties in the last decades has helped develop more collagen-based products and tissue engineering biomaterials. Collagen products have been playing an important role in benefiting the health of the human body, especially for aging people. In this paper, the effects of collagen treatment in different clinical studies including skin regeneration, bone defects, sarcopenia, wound healing, dental therapy, gastroesophageal reflux, osteoarthritis, and rheumatoid arthritis have been reviewed. The collagen treatments were significant in these clinical studies. In addition, the associations between these diseases were discussed. The comorbidity of these diseases might be closely related to collagen deficiency, and collagen treatment might be a good choice when a patient has more than one of these diseases, including the coronavirus disease 2019 (COVID-19). It concludes that collagen-based medication is useful in treating comorbid diseases and preventing complications. Full article
(This article belongs to the Special Issue Biomaterials in Medical Applications)
Show Figures

Figure 1

15 pages, 3541 KiB  
Review
MicroRNAs, Multiple Sclerosis, and Depression
by Hsiuying Wang
Int. J. Mol. Sci. 2021, 22(15), 7802; https://doi.org/10.3390/ijms22157802 - 21 Jul 2021
Cited by 28 | Viewed by 5542
Abstract
Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects the brain and spinal cord. There are several disease courses in MS including relapsing–remitting MS (RRMS), primary progressive MS (PPMS), and secondary progressive MS (SPMS). Up to 50% of [...] Read more.
Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects the brain and spinal cord. There are several disease courses in MS including relapsing–remitting MS (RRMS), primary progressive MS (PPMS), and secondary progressive MS (SPMS). Up to 50% of MS patients experience depressive disorders. Major depression (MD) is a serious comorbidity of MS. Many dysfunctions including neuroinflammation, peripheral inflammation, gut dysbiosis, chronic oxidative and nitrosative stress, and neuroendocrine and mitochondrial abnormalities may contribute to the comorbidity between MS and MD. In addition to these actions, medical treatment and microRNA (miRNA) regulation may also be involved in the mechanisms of the comorbidity between MS and MD. In the study, I review many common miRNA biomarkers for both diseases. These common miRNA biomarkers may help further explore the association between MS and MD. Full article
(This article belongs to the Special Issue Molecular Research in Multiple Sclerosis)
Show Figures

Figure 1

18 pages, 1154 KiB  
Review
MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
by Hsiuying Wang
Int. J. Mol. Sci. 2021, 22(6), 2953; https://doi.org/10.3390/ijms22062953 - 14 Mar 2021
Cited by 26 | Viewed by 5318
Abstract
Parkinson’s disease (PD) is a neurodegenerative disorder that affects 1% of the population over the age of 60. Diabetes Mellitus (DM) is a metabolic disorder that affects approximately 25% of adults over the age of 60. Recent studies showed that DM increases the [...] Read more.
Parkinson’s disease (PD) is a neurodegenerative disorder that affects 1% of the population over the age of 60. Diabetes Mellitus (DM) is a metabolic disorder that affects approximately 25% of adults over the age of 60. Recent studies showed that DM increases the risk of developing PD. The link between DM and PD has been discussed in the literature in relation to different mechanisms including mitochondrial dysfunction, oxidative stress, and protein aggregation. In this paper, we review the common microRNA (miRNA) biomarkers of both diseases. miRNAs play an important role in cell differentiation, development, the regulation of the cell cycle, and apoptosis. They are also involved in the pathology of many diseases. miRNAs can mediate the insulin pathway and glucose absorption. miRNAs can also regulate PD-related genes. Therefore, exploring the common miRNA biomarkers of both PD and DM can shed a light on how these two diseases are correlated, and targeting miRNAs is a potential therapeutic opportunity for both diseases. Full article
(This article belongs to the Special Issue Genetics of Neurodegenerative Diseases 2.0)
Show Figures

Figure 1

13 pages, 2641 KiB  
Article
Exploring the Association of Autism Spectrum Disorders and Constipation through Analysis of the Gut Microbiome
by Shih-Chen Fu, Chung-Han Lee and Hsiuying Wang
Int. J. Environ. Res. Public Health 2021, 18(2), 667; https://doi.org/10.3390/ijerph18020667 - 14 Jan 2021
Cited by 26 | Viewed by 5487
Abstract
Over the past two decades, research into the role of the gut microbiome in regulating the central nervous system has rapidly increased. Several neurodevelopmental diseases have been linked to the unbalance of gut microbiota, including autism. Children on the autism spectrum often suffer [...] Read more.
Over the past two decades, research into the role of the gut microbiome in regulating the central nervous system has rapidly increased. Several neurodevelopmental diseases have been linked to the unbalance of gut microbiota, including autism. Children on the autism spectrum often suffer from gastrointestinal symptoms, including constipation, which is four times more prevalent than it is in children without autism spectrum disorders (ASD). Although studies in animals have shown the crucial role of the microbiota in key aspects of neurodevelopment, there is currently no consensus on how the alteration of microbial composition affects the pathogenesis of ASD, let alone how it exerts an impact on the following comorbidities. In our study, we were able to control the effects of constipation on gut dysbiosis and distinguish neuropathological-related and gastrointestinal-related bacteria in ASD patients separately. By analyzing published data, eight additional bacteria significantly altered in autistic individuals were identified in our study. All of them had a decreased relative abundance in ASD patients, except Lactobacillaceae and Peptostreptococcaceae. Eighteen and eleven bacteria were significantly correlated with ASD symptoms and constipation, respectively. Among those, six bacteria were overlapped between the groups. We have found another six bacteria highly associated with constipation status in ASD patients only. By conducting Welch’s t-test, we were able to demonstrate the critical roles of microbes in ASD core and gastrointestinal symptoms and raised the hypotheses of their confounding and mediating effects on the relationship between the two symptoms. Full article
Show Figures

Figure 1

11 pages, 280 KiB  
Article
The Generalized Bayes Method for High-Dimensional Data Recognition with Applications to Audio Signal Recognition
by Hsiuying Wang
Symmetry 2021, 13(1), 19; https://doi.org/10.3390/sym13010019 - 24 Dec 2020
Cited by 1 | Viewed by 2228
Abstract
High-dimensional data recognition problem based on the Gaussian Mixture model has useful applications in many area, such as audio signal recognition, image analysis, and biological evolution. The expectation-maximization algorithm is a popular approach to the derivation of the maximum likelihood estimators of the [...] Read more.
High-dimensional data recognition problem based on the Gaussian Mixture model has useful applications in many area, such as audio signal recognition, image analysis, and biological evolution. The expectation-maximization algorithm is a popular approach to the derivation of the maximum likelihood estimators of the Gaussian mixture model (GMM). An alternative solution is to adopt a generalized Bayes estimator for parameter estimation. In this study, an estimator based on the generalized Bayes approach is established. A simulation study shows that the proposed approach has a performance competitive to that of the conventional method in high-dimensional Gaussian mixture model recognition. We use a musical data example to illustrate this recognition problem. Suppose that we have audio data of a piece of music and know that the music is from one of four compositions, but we do not know exactly which composition it comes from. The generalized Bayes method shows a higher average recognition rate than the conventional method. This result shows that the generalized Bayes method is a competitor to the conventional method in this real application. Full article
(This article belongs to the Special Issue Multidimensional Signal Processing and Its Applications)
Show Figures

Figure 1

17 pages, 472 KiB  
Review
MicroRNA, Diabetes Mellitus and Colorectal Cancer
by Hsiuying Wang
Biomedicines 2020, 8(12), 530; https://doi.org/10.3390/biomedicines8120530 - 24 Nov 2020
Cited by 23 | Viewed by 4068
Abstract
Diabetes mellitus (DM) is an endocrinological disorder that is due to either the pancreas not producing enough insulin, or the body does not respond appropriately to insulin. There are many complications of DM such as retinopathy, nephropathy, and peripheral neuropathy. In addition to [...] Read more.
Diabetes mellitus (DM) is an endocrinological disorder that is due to either the pancreas not producing enough insulin, or the body does not respond appropriately to insulin. There are many complications of DM such as retinopathy, nephropathy, and peripheral neuropathy. In addition to these complications, DM was reported to be associated with different cancers. In this review, we discuss the association between DM and colorectal cancer (CRC). CRC is the third most commonly diagnosed cancer worldwide that mostly affects older people, however, its incidence and mortality are rising among young people. We discuss the relationship between DM and CRC based on their common microRNA (miRNA) biomarkers. miRNAs are non-coding RNAs playing important functions in cell differentiation, development, regulation of cell cycle, and apoptosis. miRNAs can inhibit cell proliferation and induce apoptosis in CRC cells. miRNAs also can improve glucose tolerance and insulin sensitivity. Therefore, investigating the common miRNA biomarkers of both DM and CRC can shed a light on how these two diseases are correlated and more understanding of the link between these two diseases can help the prevention of both DM and CRC. Full article
(This article belongs to the Special Issue Diabetes and Cancers)
Show Figures

Figure 1

15 pages, 258 KiB  
Review
MicroRNAs and Apoptosis in Colorectal Cancer
by Hsiuying Wang
Int. J. Mol. Sci. 2020, 21(15), 5353; https://doi.org/10.3390/ijms21155353 - 28 Jul 2020
Cited by 108 | Viewed by 9029
Abstract
Colorectal cancer (CRC) is the third leading cause of cancer death in the world, and its incidence is rising in developing countries. Treatment with 5-Fluorouracil (5-FU) is known to improve survival in CRC patients. Most anti-cancer therapies trigger apoptosis induction to eliminate malignant [...] Read more.
Colorectal cancer (CRC) is the third leading cause of cancer death in the world, and its incidence is rising in developing countries. Treatment with 5-Fluorouracil (5-FU) is known to improve survival in CRC patients. Most anti-cancer therapies trigger apoptosis induction to eliminate malignant cells. However, de-regulated apoptotic signaling allows cancer cells to escape this signaling, leading to therapeutic resistance. Treatment resistance is a major challenge in the development of effective therapies. The microRNAs (miRNAs) play important roles in CRC treatment resistance and CRC progression and apoptosis. This review discusses the role of miRNAs in contributing to the promotion or inhibition of apoptosis in CRC and the role of miRNAs in modulating treatment resistance in CRC cells. Full article
(This article belongs to the Special Issue Survival Pathways Involved in Resistance to Apoptosis in Cancer)
Back to TopTop